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Supplementary Figure 1. Xfect/EETI-II is internalized through macropinocytosis. The image shows membrane ruffles engulfing coagulated rEETI-II-Alexa488. HeLa cells were treated with Xfect/rEETI-II-A488 for 30 min and then fixed with PFA-GA. Scale bar, 500 nm. Figure 3 . Cellular uptake of rEETI-II is reduced upon treatment of cells with nocodazole, an inhibitor of microtubule polymerization, or ikarugamycin, an inhibitor of clathrin-mediated endocytosis. HeLa cells were treated with DMSO, nocodazole (10 μM) or ikarugamycin (4 μM) for 30 min, and then with rEETI-II-A488 (5 μM) in the presence or absence of nocodazole (10 μ M) or ikarugamycin (4 μM) for 60 min at 37°C. Cells were washed with PBS and then fixed with 4% PFA, imaged and processed as described in methods. Values were normalized to the DMSO-treated samples and averaged from six independent experiments. Mean ± SD. n = 5500 cells. Representative images from six independent experiments are shown. Scale bar, 20 µm. Internalized rEETI-II localization is sensitive to detergent permeabilization. HeLa cells were treated with 5 μM rEETI-II-A488 for 60 min and then fixed with 4% PFA as described in methods. Cells were then incubated with PBS, 0.1 % Triton X-100, 0.04 % Saponin, 0.01 % Saponin, or 25 μM Digitonin in PBS for 5 min at room temperature, washed and imaged as described in methods. Values were normalized to the PBS-treated samples. Mean ± SD. n = 1000 cells. Representative images from at least three independent experiments are shown. Scale bar, 20 μm. 
